Rimegepant
| CAS No. | 1289023-67-1 | Cat. No. | BCP28575 |
| Name | Rimegepant | ||
| Synonyms | BHV-3000; BHV 3000; BHV3000;BMS 927711; BMS927711; BMS-927711; | ||
| Formula | C28H28F2N6O3 | M. Wt | 534.56 |
| Description | Rimegepant, also known as BMS-927711, is a potent, selective, competitive and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine. Rimegepant has shown in vivo efficacy without vasoconstrictor effect. BMS-927711 is superior to placebo at several different doses (75 mg, 150 mg, and 300 mg) and has an excellent tolerability profile. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | CGRP Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.